International Biotechnology Trust as of March 31, 2019
Portfolio Holdings for International Biotechnology Trust
International Biotechnology Trust holds 62 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Celgene Corporation | 8.2 | $22M | 236k | 94.32 | |
| Gilead Sciences (GILD) | 6.7 | $18M | 278k | 65.02 | |
| Regeneron Pharmaceuticals (REGN) | 4.8 | $13M | 32k | 410.53 | |
| D Stemline Therapeutics | 3.8 | $10M | 796k | 12.85 | |
| Alexion Pharmaceuticals | 3.7 | $10M | 74k | 135.14 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 3.5 | $9.4M | 51k | 183.87 | |
| Neurocrine Biosciences (NBIX) | 3.4 | $9.1M | 104k | 88.11 | |
| Ptc Therapeutics I (PTCT) | 3.3 | $9.0M | 241k | 37.63 | |
| Incyte Corporation (INCY) | 3.2 | $8.7M | 102k | 85.99 | |
| Alkermes (ALKS) | 3.1 | $8.5M | 233k | 36.49 | |
| Illumina (ILMN) | 2.9 | $7.8M | 25k | 310.72 | |
| Halozyme Therapeutics (HALO) | 2.8 | $7.7M | 476k | 16.10 | |
| ACADIA Pharmaceuticals (ACAD) | 2.7 | $7.2M | 269k | 26.84 | |
| Aerie Pharmaceuticals | 2.6 | $7.2M | 151k | 47.50 | |
| Kalvista Pharmaceuticals (KALV) | 2.2 | $6.1M | 213k | 28.45 | |
| Enanta Pharmaceuticals (ENTA) | 2.1 | $5.8M | 61k | 95.52 | |
| Exelixis (EXEL) | 2.1 | $5.8M | 244k | 23.79 | |
| BioMarin Pharmaceutical (BMRN) | 2.1 | $5.7M | 64k | 88.73 | |
| Wave Life Sciences (WVE) | 2.1 | $5.6M | 145k | 38.84 | |
| Sage Therapeutics (SAGE) | 2.0 | $5.4M | 34k | 159.05 | |
| Zogenix | 1.9 | $5.1M | 93k | 54.99 | |
| Retrophin | 1.7 | $4.7M | 208k | 22.61 | |
| Amgen (AMGN) | 1.7 | $4.6M | 24k | 189.92 | |
| Seattle Genetics | 1.6 | $4.5M | 61k | 73.23 | |
| Ionis Pharmaceuticals (IONS) | 1.4 | $3.9M | 48k | 81.14 | |
| Horizon Pharma | 1.2 | $3.4M | 128k | 26.42 | |
| Abiomed | 1.2 | $3.3M | 12k | 285.56 | |
| Insmed (INSM) | 1.2 | $3.2M | 110k | 29.07 | |
| Alnylam Pharmaceuticals (ALNY) | 1.2 | $3.2M | 34k | 93.49 | |
| Supernus Pharmaceuticals (SUPN) | 1.2 | $3.2M | 90k | 35.02 | |
| Intersect Ent | 1.1 | $3.1M | 96k | 32.16 | |
| Amarin Corporation | 1.1 | $2.8M | 137k | 20.74 | |
| Gw Pharmaceuticals Plc ads | 1.1 | $2.8M | 17k | 168.51 | |
| Bluebird Bio | 1.0 | $2.7M | 17k | 157.35 | |
| Agios Pharmaceuticals (AGIO) | 0.9 | $2.5M | 37k | 67.45 | |
| Biogen Idec (BIIB) | 0.8 | $2.2M | 9.5k | 236.32 | |
| Radius Health | 0.8 | $2.1M | 106k | 19.93 | |
| Akcea Therapeutics Inc equities | 0.8 | $2.1M | 75k | 28.28 | |
| Nektar Therapeutics | 0.7 | $2.0M | 60k | 33.60 | |
| Array BioPharma | 0.7 | $1.8M | 73k | 24.37 | |
| Sutro Biopharma (STRO) | 0.6 | $1.7M | 147k | 11.39 | |
| Sarepta Therapeutics (SRPT) | 0.6 | $1.6M | 14k | 119.06 | |
| Ascendis Pharma A S (ASND) | 0.6 | $1.6M | 14k | 117.68 | |
| G1 Therapeutics | 0.6 | $1.6M | 99k | 16.56 | |
| Mirati Therapeutics | 0.6 | $1.6M | 22k | 73.27 | |
| Myokardia | 0.6 | $1.6M | 30k | 51.97 | |
| Biohaven Pharmaceutical Holding | 0.6 | $1.5M | 30k | 51.47 | |
| Global Blood Therapeutics In | 0.6 | $1.5M | 28k | 52.89 | |
| Acceleron Pharma | 0.5 | $1.4M | 30k | 46.53 | |
| Myriad Genetics (MYGN) | 0.5 | $1.3M | 38k | 33.18 | |
| Inflarx Nv (IFRX) | 0.5 | $1.2M | 33k | 37.63 | |
| Globus Med Inc cl a (GMED) | 0.4 | $1.2M | 24k | 49.42 | |
| Fibrogen | 0.4 | $1.1M | 20k | 54.37 | |
| Ligand Pharmaceuticals In (LGND) | 0.3 | $918k | 7.3k | 125.75 | |
| Millendo Therapeutics | 0.3 | $925k | 62k | 14.95 | |
| Momenta Pharmaceuticals | 0.3 | $792k | 55k | 14.51 | |
| Amicus Therapeutics (FOLD) | 0.3 | $796k | 59k | 13.58 | |
| Tricida | 0.3 | $751k | 19k | 39.39 | |
| Arena Pharmaceuticals | 0.3 | $740k | 17k | 44.85 | |
| Sangamo Biosciences (SGMO) | 0.2 | $457k | 48k | 9.52 | |
| Dermira | 0.1 | $407k | 30k | 13.57 | |
| Macrogenics (MGNX) | 0.1 | $342k | 19k | 18.00 |
